AR022469A1 - USE OF SUBSTITUTED AND DERIVATIVE ISOXAZOLCARBOXILIC ACIDS AND NEW SUBSTANCES - Google Patents

USE OF SUBSTITUTED AND DERIVATIVE ISOXAZOLCARBOXILIC ACIDS AND NEW SUBSTANCES

Info

Publication number
AR022469A1
AR022469A1 ARP000100427A ARP000100427A AR022469A1 AR 022469 A1 AR022469 A1 AR 022469A1 AR P000100427 A ARP000100427 A AR P000100427A AR P000100427 A ARP000100427 A AR P000100427A AR 022469 A1 AR022469 A1 AR 022469A1
Authority
AR
Argentina
Prior art keywords
acids
substituted
isoxazolcarboxilic
derivative
new substances
Prior art date
Application number
ARP000100427A
Other languages
Spanish (es)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of AR022469A1 publication Critical patent/AR022469A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Abstract

La presente invencion se refiere al uso de ácidos isoxazolcarboxílicos sustituidos y derivados de formula general (1) para el tratamiento y profilaxis deenfermedades de anemias, así como de nuevas sustancias de formula general (2) y a nuevos procedimientos para su obtencion.The present invention relates to the use of substituted isoxazolcarboxylic acids and derivatives of the general formula (1) for the treatment and prophylaxis of anemia diseases, as well as new substances of the general formula (2) and to new methods for obtaining them.

ARP000100427A 1999-02-04 2000-02-01 USE OF SUBSTITUTED AND DERIVATIVE ISOXAZOLCARBOXILIC ACIDS AND NEW SUBSTANCES AR022469A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19904389A DE19904389A1 (en) 1999-02-04 1999-02-04 Use of substituted isoxazolecarboxylic acids and derivatives and new substances

Publications (1)

Publication Number Publication Date
AR022469A1 true AR022469A1 (en) 2002-09-04

Family

ID=7896332

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000100427A AR022469A1 (en) 1999-02-04 2000-02-01 USE OF SUBSTITUTED AND DERIVATIVE ISOXAZOLCARBOXILIC ACIDS AND NEW SUBSTANCES

Country Status (5)

Country Link
AR (1) AR022469A1 (en)
AU (1) AU2110000A (en)
DE (1) DE19904389A1 (en)
GT (1) GT200000011A (en)
WO (1) WO2000045799A2 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6320998A (en) 1997-02-21 1998-09-09 Bristol-Myers Squibb Company Benzoic acid derivatives and related compounds as antiarrhythmic agents
MY151199A (en) 2001-11-02 2014-04-30 Rigel Pharmaceuticals Inc Substituted diphenyl heterocycles useful for treating hcv infection
AU2003262831A1 (en) 2002-08-23 2004-03-11 Rigel Pharmaceuticals, Inc. Pyridyl substituted heterocycles useful for treating or preventing hcv infection
WO2004099165A2 (en) 2003-05-02 2004-11-18 Rigel Pharmaceuticals, Inc. Heterocyclic compounds and hydro isomers thereof
US7115642B2 (en) 2003-05-02 2006-10-03 Rigel Pharmaceuticals, Inc. Substituted diphenyl isoxazoles, pyrazoles and oxadiazoles useful for treating HCV infection
US7220745B2 (en) 2003-05-15 2007-05-22 Rigel Pharmaceuticals Heterocyclic compounds useful to treat HCV
US8580842B2 (en) 2003-09-30 2013-11-12 Abbott Gmbh & Co. Kg Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
WO2005049065A2 (en) 2003-11-19 2005-06-02 Rigel Pharmaceuticals, Inc. Synergistic combinations of dihaloacetamide with interferon or ribavirin for treatment hcv infections
US7514434B2 (en) 2004-02-23 2009-04-07 Rigel Pharmaceuticals, Inc. Heterocyclic compounds having an oxadiazole moiety and hydro isomers thereof
JP2008515992A (en) 2004-10-13 2008-05-15 ピーティーシー セラピューティクス，インコーポレーテッド Use of prescribed compounds for the manufacture of medicaments for the prevention / treatment of diseases caused by somatic mutations
EP1883633A2 (en) 2005-05-02 2008-02-06 Rigel Pharmaceuticals, Inc. Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses
WO2006131336A1 (en) * 2005-06-08 2006-12-14 Novartis Ag POLYCYCLIC OXADIAZOLES OR I SOXAZOLES AND THEIR USE AS SlP RECEPTOR LIGANDS
GB0601744D0 (en) * 2006-01-27 2006-03-08 Novartis Ag Organic compounds
SI2069336T1 (en) 2006-09-07 2013-03-29 Actelion Pharmaceuticals Ltd. Pyridin-4-yl derivatives as immunomodulating agents
PL2069335T3 (en) * 2006-09-08 2013-05-31 Actelion Pharmaceuticals Ltd Pyridin-3-yl derivatives as immunomodulating agents
US20080167286A1 (en) 2006-12-12 2008-07-10 Abbott Laboratories Pharmaceutical compositions and their methods of use
US8486979B2 (en) 2006-12-12 2013-07-16 Abbvie Inc. 1,2,4 oxadiazole compounds and methods of use thereof
UY30846A1 (en) 2006-12-30 2008-07-31 Abbott Gmbh & Amp OXINDOL DERIVATIVES REPLACED, MEDICINES THAT UNDERSTAND AND USE THEMSELVES
WO2008114157A1 (en) 2007-03-16 2008-09-25 Actelion Pharmaceuticals Ltd Amino- pyridine derivatives as s1p1 /edg1 receptor agonists
EP3311813B1 (en) 2007-08-27 2019-08-07 Dart Neuroscience (Cayman) Ltd Therapeutic isoxazole compounds
MX2010006202A (en) 2007-12-07 2011-03-04 Abbott Gmbh & Co Kg Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses.
BRPI0820668A2 (en) 2007-12-07 2017-08-22 Abbott Gmbh & Co Kg 5-HALOGEN SUBSTITUTED OXINDOL DERIVATIVES AND THEIR USE TO TREAT VASOPRESSIN DEPENDENT DISEASES
CA2707671C (en) 2007-12-07 2016-02-02 Abbott Gmbh & Co. Kg 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases
WO2010009775A1 (en) 2007-12-07 2010-01-28 Abbott Gmbh & Co. Kg Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases
WO2010138600A2 (en) 2009-05-29 2010-12-02 Abbott Laboratories Pharmaceutical compositions for the treatment of pain
MX2012000435A (en) 2009-07-08 2012-06-01 Dermira Canada Inc Tofa analogs useful in treating dermatological disorders or conditions.
JP5036923B1 (en) 2009-07-16 2012-09-26 アクテリオン ファーマシューティカルズ リミテッド Pyridin-4-yl derivative
US9133179B2 (en) 2011-01-19 2015-09-15 Actelion Pharmaceuticals Ltd. 2-methoxy-pyridin-4-yl-derivatives
CN102329277B (en) * 2011-10-24 2013-08-07 海南霞迪药业有限公司 Method for preparing Parecoxib
BR112017024785B1 (en) 2015-05-20 2022-05-17 Idorsia Pharmaceuticals Ltd CRYSTALLINE FORM OF COMPOUND (S)-3-{4-[5-(2-CYCLOPENTYL-6-METOXY-PYRIDIN-4-YL)-[1,2,4]OXADIAZOLE-3-YL]-2-ETHYL- 6-METHYLPHENOXY}-PROPANE-1,2-DIOL, PHARMACEUTICAL COMPOSITION, AND USE
CN116535399B (en) * 2022-01-25 2024-02-27 中国药科大学 3-hydroxy-5- (isoxazol-5-yl) pyridine formyl glycine compound, preparation method, pharmaceutical composition and application

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB149877A (en) * 1919-11-22 1920-08-26 Arthur William Wells Improvements in and in connection with safety razors
DE3065860D1 (en) * 1979-02-22 1984-01-19 Monsanto Co Thermolysis of 2-(3-aryl-isoxazol-5-yl)benzoic acids, salts and halides from 3'-(aryl)-spiro(isobenzofuran-1(3h),5'(4'h)isoxazol)-3-ones
US5330994A (en) * 1992-03-24 1994-07-19 Warner-Lambert Company Tetrahydropyridine isoxazoline derivatives
DE4314966A1 (en) * 1993-05-06 1994-11-10 Fahlberg List Pharma Gmbh 2-Hydroxyphenyl-substituted isoxazoles, the use thereof as pharmaceutical agents and pharmaceutical compositions containing them
WO1997019039A1 (en) * 1995-11-17 1997-05-29 Novartis Ag Solid phase synthesis of heterocyclic compounds and combinatorial compound library
DE19640370C1 (en) * 1996-09-30 1998-02-12 Dornier Gmbh Lindauer Assemblies to hold and guide loom shaft rods
WO1998057923A1 (en) * 1997-06-18 1998-12-23 Fujisawa Pharmaceutical Co., Ltd. New production process

Also Published As

Publication number Publication date
WO2000045799A3 (en) 2002-01-24
WO2000045799A2 (en) 2000-08-10
GT200000011A (en) 2001-07-27
DE19904389A1 (en) 2000-08-10
AU2110000A (en) 2000-08-25

Similar Documents

Publication Publication Date Title
AR022469A1 (en) USE OF SUBSTITUTED AND DERIVATIVE ISOXAZOLCARBOXILIC ACIDS AND NEW SUBSTANCES
CY1121202T1 (en) PYRROL PRODUCTS [2,3-b)] PYRIMIDINE AS A MOVEMENT INHIBITOR JANUS
CY1119261T1 (en) THEIAZOLI PRODUCTS
HN1999000124A (en) SUBSTITUTED PYRAZOLE DERIVATIVES.
BRPI0409611A (en) piperazine derivatives and their use for the treatment of neurological and psychiatric disorders
EA200600621A1 (en) DERIVATIVES OF TETRAHYDRONAPTALINE, METHOD OF THEIR PRODUCTION AND THEIR USE AS ANTI-INFLAMMATORY MEANS
DE60204452D1 (en) [1,5] pyridine derivatives
SV1999000047A (en) NEW DIHYDROPYRIMIDINES FEF. READ 32792-SV
UY26495A1 (en) "THIAZOLYLAMIDE DERIVATIVES"
AR047529A1 (en) SUBSTITUTED QUINOLINE COMPOUNDS
GT200100137A (en) PRO-DRUGS OF 4-PHENYL-PYRIDINE DERIVATIVES.
CY1109558T1 (en) Benzo derivative [D] AZEPINIS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
NO20021358D0 (en) Alkylenediamine-substituted heterocycles
PA8551001A1 (en) NEW COMPOUNDS
ATE524181T1 (en) USE OF 1,4-BIS(3-AMINOALKYL) PIPERAZINE DERIVATIVES IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
ES2243579T3 (en) DERIVATIVES OF PIRAZOLOPIRIDENO.
CR9182A (en) DERIVATIVE OF QUINOLINA, ITS USE, PREPARATION AND MEDICINAL PRODUCT CONTAINING IT
ECSP045469A (en) THE USE OF REPLACED CYANOPIRROLIDINS AND COMBINATION PREPARATIONS CONTAINING THEM TO TREAT HYPERLIPIDEMIA AND ASSOCIATED DISEASES
PA8573501A1 (en) BENZOXAZINE DERIVATIVES AND THEIR EMPLOYMENT
EE200200466A (en) 8,8a-Dihydroindeno [1,2-d] thiazole derivatives substituted at 8a position, process for their preparation as medicaments, for example as anorectic agents
UY26133A1 (en) SUBSTITUTED DERIVATIVE OF PYRAZOLE.
BRPI0409376A (en) indene derivatives as pharmaceutical agents
ECSP034754A (en) DERIVATIVES OF BETA-CARBOLINA AND ITS PHARMACEUTICAL USE AGAINST DEPRESSION AND ANXIETY
UY27451A1 (en) 2,5-DIAMIDOINDOLES REPLACED AND ITS USE
BR0114380A (en) 1-Aminobutan-3-ol-substituted derivatives